Literature DB >> 24293823

Diversity of Hepatitis C virus in Southern India Based on 5'UTR Sequence.

R Amjesh1, Achuthsankar S Nair, V S Sugunan.   

Abstract

Hepatitis C virus (HCV) exhibits genotype-specific variations in geographical distribution as a consequence of drug and immune induced evolution. Present study was aimed at discerning the distribution and prevalence of the various genotypes and subtypes of HCV in southern India. The HCV positive patient's serum was collected from different hospitals and blood banks from the states of Kerala, Tamil Nadu, Andhra Pradesh and Karnataka. Among 114 HCV positive samples, we could find only 44 isolates that are found both positive in ELISA and RT-PCR. From these samples 5' untranslated region (5'UTR) were amplified, sequenced and sub typed. Analysis of 5'UTR region of the 44 isolates shows that, genotypes 1, 3, 4 and 6 are present with genotype 3 being the most frequent. The present study shows that HCV genotype 3 subtype B was the most prevalent, forming 47.7 % among the population in southern India. The present study urges for discovering novel therapeutic agents that should be specific to genotype 3 subtype B, for the management of HCV in southern India.

Entities:  

Year:  2012        PMID: 24293823      PMCID: PMC3550797          DOI: 10.1007/s13337-012-0103-2

Source DB:  PubMed          Journal:  Indian J Virol        ISSN: 0970-2822


  25 in total

Review 1.  Perspectives for a vaccine against hepatitis C virus.

Authors:  S Abrignani; M Houghton; H H Hsu
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

2.  MEGA: Molecular Evolutionary Genetics Analysis software for microcomputers.

Authors:  S Kumar; K Tamura; M Nei
Journal:  Comput Appl Biosci       Date:  1994-04

Review 3.  Clinical significance of hepatitis C virus genotypes.

Authors:  N N Zein
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

4.  Hepatitis C virus genotype 6 infection in India.

Authors:  Sukanya Raghuraman; Priya Abraham; Gopalan Sridharan; B S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2005 Mar-Apr

5.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

6.  Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes.

Authors:  A S Abdulkarim; N N Zein; J J Germer; C P Kolbert; L Kabbani; K L Krajnik; A Hola; M N Agha; M Tourogman; D H Persing
Journal:  Am J Trop Med Hyg       Date:  1998-10       Impact factor: 2.345

7.  Differences in the hepatitis C virus genotypes in different countries.

Authors:  N Takada; S Takase; A Takada; T Date
Journal:  J Hepatol       Date:  1993-03       Impact factor: 25.083

8.  Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group.

Authors:  N N Zein; J Rakela; E L Krawitt; K R Reddy; T Tominaga; D H Persing
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

Review 9.  Genetic diversity and evolution of hepatitis C virus--15 years on.

Authors:  Peter Simmonds
Journal:  J Gen Virol       Date:  2004-11       Impact factor: 3.891

10.  Evidence of intratypic recombination in natural populations of hepatitis C virus.

Authors:  Rodney Colina; Didier Casane; Silvia Vasquez; Laura García-Aguirre; Ausberto Chunga; Héctor Romero; Baldip Khan; Juan Cristina
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

View more
  1 in total

1.  Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India.

Authors:  Mary A Rodgers; Selvamurthi Gomathi; Ana Vallari; Shanmugam Saravanan; Gregory M Lucas; Shruti Mehta; Sunil S Solomon; Gavin A Cloherty
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.